172
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Antagonizing effect of icaritin on apoptosis and injury of hippocampal neurocytes induced by amyloid beta via GR/BDNF signaling pathway

, , &
Pages 550-559 | Received 26 Feb 2020, Accepted 10 May 2020, Published online: 01 Jun 2020

References

  • Isaev NK, Stelmashook EV, Genrikhs EE, et al. Alzheimer’s disease: an exacerbation of senile phenoptosis. Biochem Mosc. 2015;80(12):1578–1581.
  • 2016 Alzheimer’s disease facts and figures. Alzheim Dement J Alzheim Assoc. 2016;12(4):459–509.
  • Schoemaker D, Gauthier S, Pruessner JC. Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer’s disease: a literature review. Neuropsychol Rev. 2014;24(3):313–331.
  • Jack CR, Jr., Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119–128.
  • Murphy MP, LeVine H. 3rd. Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis. 2010;19(1):311–323.
  • Roßner S, Sastre M, Bourne K, et al. Transcriptional and translational regulation of BACE1 expression–implications for Alzheimer’s disease. Progr Neurobiol. 2006;79(2):95–111.
  • Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356.
  • Reiss AB, Arain HA, Stecker MM, et al. Amyloid toxicity in Alzheimer’s disease. Rev Neurosci. 2018;29(6):613–627.
  • Glabe CG. Structural classification of toxic amyloid oligomers. J Biol Chem. 2008;283(44):29639–29643.
  • Stefani M. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J. 2010;277(22):4602–4613.
  • Tanaka M, Chien P, Naber N, et al. Conformational variations in an infectious protein determine prion strain differences. Nature. 2004;428(6980):323–328.
  • King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature. 2004;428(6980):319–323.
  • Zhang XN, Wang HH, Wang ZQ. [Protective effect of icaritin on apoptosis of primarily cultured rat neurons induced by Abeta25-35 peptide]. J Zhejiang Univ Med Sci. 2007;36(3):224–228.
  • Jiang MC, Chen XH, Zhao X, et al. Involvement of IGF-1 receptor signaling pathway in the neuroprotective effects of Icaritin against MPP(+)-induced toxicity in MES23.5 cells. Eur J Pharmacol. 2016;786:53–59.
  • Liu L, Zhao Z, Lu L, et al. Icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice. Int Immunopharmacol. 2019;75:105799.
  • Wang Z, Zhang X, Wang H, et al. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience. 2007;145(3):911–922.
  • Grimholt RM, Urdal P, Klingenberg O, et al. Correction to: rapid and reliable detection of α-globin copy number variations by quantitative real-time PCR. BMC Hematol. 2019;19:13.
  • Gaspar RC, Villarreal SA, Bowles N, et al. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Exp Neurol. 2010;223(2):394–400.
  • Pike KE, Ellis KA, Villemagne VL, et al. Cognition and beta-amyloid in preclinical Alzheimer’s disease: data from the AIBL study. Neuropsychologia. 2011;49(9):2384–2390.
  • Haass C, Kaether C, Thinakaran G, et al. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012;2(5):a006270.
  • Kaminsky YG, Marlatt MW, Smith MA, et al. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Exp Neurol. 2010;221(1):26–37.
  • Petry FDS, Coelho BP, Gaelzer MM, et al. Genistein protects against amyloid-beta-induced toxicity in SH-SY5Y cells by regulation of Akt and Tau phosphorylation. Phytother Res PTR. 2020;34(4):796–807.
  • Leong YQ, Ng KY, Chye SM, et al. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Metab Brain Dis. 2020;35(1):11–30.
  • Dong W, Wang F, Guo W, et al. Aβ25-35 suppresses mitochondrial biogenesis in primary hippocampal neurons. Cell Mol Neurobiol. 2016;36(1):83–91.
  • Zhang YW, Morita I, Zhang L, et al. Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication. Planta Med. 2000;66(2):119–123.
  • Wang ZQ, Lou YJ. Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur J Pharmacol. 2004;504(3):147–153.
  • Wang ZQ, Weber N, Lou YJ, et al. Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships. ChemMedChem. 2006;1(4):482–488.
  • Ernfors P, Wetmore C, Olson L, et al. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron. 1990;5(4):511–526.
  • Hohn A, Leibrock J, Bailey K, et al. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 1990;344(6264):339–341.
  • Lipsky RH, Marini AM. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann NY Acad Sci. 2007;1122:130–143.
  • Yamada K, Mizuno M, Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002;70(7):735–744.
  • Kawamoto Y, Nakamura S, Nakano S, et al. Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain. Neuroscience. 1996;74(4):1209–1226.
  • Le Menuet D, Lombes M. The neuronal mineralocorticoid receptor: from cell survival to neurogenesis. Steroids. 2014;91:11–19.
  • Khani-Habibabadi F, Askari S, Zahiri J, et al. Novel BDNF-regulatory microRNAs in neurodegenerative disorders pathogenesis: an in silico study. Comput Biol Chem. 2019;83:107153.
  • Rosa E, Fahnestock M. CREB expression mediates amyloid β-induced basal BDNF downregulation. Neurobiol Aging. 2015;36(8):2406–2413.
  • Chen Q, Ma H, Guo X, et al. Farnesoid X receptor (FXR) aggravates amyloid-β-triggered apoptosis by modulating the cAMP-response element-binding protein (CREB)/brain-derived neurotrophic factor (BDNF) pathway in vitro. Med Sci Monit. 2019;25:9335–9345.
  • Arango-Lievano M, Borie AM, Dromard Y, et al. Persistence of learning-induced synapses depends on neurotrophic priming of glucocorticoid receptors. Proc Natl Acad Sci USA. 2019;116(26):13097–13106.
  • Yang Y, Yang S, Liu J, et al. DNA hypomethylation of GR promoters is associated with GR activation and BDNF/AKT/ERK1/2-induced hippocampal neurogenesis in mice derived from folic-acid-supplemented dams. Mol Nutr Food Res. 2019;63(12):e1801334.
  • Finsterwald C, Alberini CM. Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem. 2014;112:17–29.
  • Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 2012;64(2):238–258.
  • Harward SC, Hedrick NG, Hall CE, et al. Autocrine BDNF-TrkB signalling within a single dendritic spine. Nature. 2016;538(7623):99–103.
  • Zhang RY, Zhang L, Ai HX, et al. Effects of icariin on beta-amyloid and neurotrophic factors in brain of mitochondrial deficiency model rats]. Zhong Zhong Zhi. 2013;38(9):1285–1289.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.